Literature DB >> 14363609

Evaluation of an androgen, methylandrostenediol, in the treatment of diabetic retinopathy.

K J GURLING.   

Abstract

Entities:  

Keywords:  ANDROGENS/therapeutic use; DIABETES MELLITUS/complications; RETINA/diseases

Mesh:

Substances:

Year:  1955        PMID: 14363609      PMCID: PMC1324530          DOI: 10.1136/bjo.39.3.151

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  [Activity of testosterone implants in diabetics].

Authors:  H P KLOTZ; J AVRIL
Journal:  Bull Mem Soc Med Hop Paris       Date:  1952 Nov 21-28

2.  Diabetic retinopathy treated with testosterone.

Authors:  R H BEDROSSIAN; D S POCOCK; W F HARVEY; A S SINDONI
Journal:  AMA Arch Ophthalmol       Date:  1953-09

3.  Methylandrostenediol in palliative treatment of breast cancer.

Authors:  S C KASDON; W H FISHMAN; R M DART; C D BONNER; F HOMBURGER
Journal:  J Am Med Assoc       Date:  1952-04-05

4.  Diabetic retinopathy. A new approach to therapy with a steroid hormone-testosterone propionate.

Authors:  E SASKIN; S WALDMAN; L PELNER
Journal:  Am J Ophthalmol       Date:  1951-04       Impact factor: 5.258

5.  Methylandrostenediol.

Authors:  E HENDERSON; M WEINBERG
Journal:  J Clin Endocrinol Metab       Date:  1951-06       Impact factor: 5.958

  5 in total
  2 in total

1.  Permanent bilateral blindness following the use of hexamethonium chloride.

Authors:  G M BRUCE
Journal:  Trans Am Ophthalmol Soc       Date:  1955

2.  Flavonoid therapy in diabetic retinopathy.

Authors:  P M BRICKLEY; B L GIFFORD; C A DOMZ
Journal:  Calif Med       Date:  1959-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.